Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax COIN Option Income Strategy ETF (CONY) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

YieldMax COIN Option Income Strategy ETFTrade
Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

YieldMax COIN Option Income Strategy ETF vs Inovio Pharmaceuticals Inc — how do they compare? YieldMax COIN Option Income Strategy ETF trades at $18.3, while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). Which is the better fit depends on your goals.

CONYINO
Sector
Income / Options OverlayHealth
52-Week High
$76.50$2.87
52-Week Low
$17.80$0.66
Market Cap
$78.55M
Enterprise Value
$49.56M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax COIN Option Income Strategy ETF

CONY trades at $18.11, up 0.22% on the day, with a bearish technical signal driven by moving averages. The ETF shows no available valuation or profitability ratios, and recent news highlights weekly dividend distributions but also concerns over shareholder losses and declining value despite high yields. Technical indicators show RSI near oversold levels at 29.18, suggesting potential for a rebound, while resistance sits at $19.

The outlook remains cautious due to bearish technicals and negative media sentiment questioning sustainability. Risks include reliance on options income and market volatility. Analyst coverage is limited, with no consensus ratings or price targets available, indicating uncertainty for investors.

Inovio Pharmaceuticals Inc

INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.

The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.

Returns comparison

Trailing returns across standard periods

About YieldMax COIN Option Income Strategy ETF

CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.

Read more on CONY

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO